🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Mini-dose MTX Plus Standard-dose Steroid for the Initial Treatment of Acute GVHD

RecruitingPhase 3Ages 15 Years - 65 YearsAllPeking University People's Hospital
NCT05921305 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This trial is a randomized (1:1) phase III open label study of frontline mini-MTX plus methylprednisolone 2mg/kg/day compared to methylprednisolone 2mg/kg in allogeneic stem cell transplant recipients with grade 2-4 aGVHD.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Patients who are fully informed and sign informed consent by themselves or their guardians; 2. Patients receiving first allogeneic hematopoietic stem cell transplantation; 3. Patients with acute graft-versus-host disease of grade II-IV were diagnosed after transplantation; 4. KPS\>60, Estimated survival \>3 months; 5. No serious organ damage: 1. ANC in peripheral blood is greater than 0.5×109/l 2. Creatinine \< 1.5mg/dl 3. Cardiac ejection index \> 55% Exclusion Criteria: 1. Patients with severe brain, heart, kidney or liver dysfunction unrelated to graft-versus host disease; 2. Patients with uncontrollable active infection; 3. Patients with recurrence of primary malignant hematopathy; 4. Expected survival is less than 3 months 5. Patients who have histories of severe allergic reactions 6. Pregnant or lactating women 7. The researcher judges that there are other factors that are not suitable for participating 8. Patients who received donor lymphocyte infusion
💊

What it tests

  • MTX
  • Corticosteroid
📍

Where

2 sites
Peking University Institute of Hematology,
Beijing, China
Nanfang Hospital, Nanfang Medical University
Guangzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy